| Increased Bax/Bcl-2 ratio up-regulates caspase-3 and increases apoptosis in the thymus of patients with myasthenia gravis S Salakou, D Kardamakis, AC Tsamandas, V Zolota, E Apostolakis, ... In vivo 21 (1), 123-132, 2007 | 382 | 2007 |
| Effects of abiraterone acetate on androgen signaling in castrate-resistant prostate cancer in bone E Efstathiou, M Titus, D Tsavachidou, V Tzelepi, S Wen, A Hoang, ... Journal of clinical oncology 30 (6), 637-643, 2012 | 236 | 2012 |
| Modeling a lethal prostate cancer variant with small-cell carcinoma features V Tzelepi, J Zhang, JF Lu, B Kleb, G Wu, X Wan, A Hoang, E Efstathiou, ... Clinical cancer research 18 (3), 666-677, 2012 | 170 | 2012 |
| Therapeutic targeting of the prostate cancer microenvironment M Karlou, V Tzelepi, E Efstathiou Nature Reviews Urology 7 (9), 494-509, 2010 | 136 | 2010 |
| Persistent, biologically meaningful prostate cancer after 1 year of androgen ablation and docetaxel treatment V Tzelepi, E Efstathiou, S Wen, P Troncoso, M Karlou, CA Pettaway, ... Journal of clinical oncology 29 (18), 2574-2581, 2011 | 97 | 2011 |
| Integrative molecular profiling reveals asparagine synthetase is a target in castration-resistant prostate cancer K Sircar, H Huang, L Hu, D Cogdell, J Dhillon, V Tzelepi, E Efstathiou, ... The American journal of pathology 180 (3), 895-903, 2012 | 94 | 2012 |
| High expression of BCL-2 predicts favorable outcome in non-small cell lung cancer patients with non squamous histology VK Anagnostou, FJ Lowery, V Zolota, V Tzelepi, A Gopinath, C Liceaga, ... BMC cancer 10, 1-11, 2010 | 94 | 2010 |
| Neuroendocrine prostate cancer xenografts with large‐cell and small‐cell features derived from a single patient's tumor: Morphological, immunohistochemical, and gene expression … A Aparicio, V Tzelepi, JC Araujo, CC Guo, S Liang, P Troncoso, ... The Prostate 71 (8), 846-856, 2011 | 91 | 2011 |
| The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and … AC Tsamandas, D Kardamakis, P Tsiamalos, A Liava, V Tzelepi, ... Anticancer research 29 (2), 703-709, 2009 | 90 | 2009 |
| Activation of β-catenin signaling in androgen receptor–negative prostate Cancer cells X Wan, J Liu, JF Lu, V Tzelepi, J Yang, MW Starbuck, L Diao, J Wang, ... Clinical cancer research 18 (3), 726-736, 2012 | 89 | 2012 |
| Tight junctions in thyroid carcinogenesis: diverse expression of claudin-1, claudin-4, claudin-7 and occludin in thyroid neoplasms VN Tzelepi, AC Tsamandas, HD Vlotinou, CE Vagianos, CD Scopa Modern pathology 21 (1), 22-30, 2008 | 82 | 2008 |
| Differentially methylated genes and androgen receptor re-expression in small cell prostate carcinomas B Kleb, MRH Estécio, J Zhang, V Tzelepi, W Chung, J Jelinek, ... Epigenetics 11 (3), 184-193, 2016 | 81 | 2016 |
| Epigenetic alterations in triple-negative breast cancer—the critical role of extracellular matrix V Zolota, V Tzelepi, Z Piperigkou, H Kourea, E Papakonstantinou, ... Cancers 13 (4), 713, 2021 | 55 | 2021 |
| Expression of hedgehog pathway components in prostate carcinoma microenvironment: shifting the balance towards autocrine signalling V Tzelepi, M Karlou, S Wen, A Hoang, C Logothetis, P Troncoso, ... Histopathology 58 (7), 1037-1047, 2011 | 52 | 2011 |
| Prognostic value of novel biomarkers in astrocytic brain tumors: nuclear receptor co-regulators AIB1, TIF2, and PELP1 are associated with high tumor grade and worse patient … Z Kefalopoulou, V Tzelepi, V Zolota, PD Grivas, C Christopoulos, ... Journal of neuro-oncology 106, 23-31, 2012 | 48 | 2012 |
| Expression of claudins-1,-4,-5,-7 and occludin in hepatocellular carcinoma and their relation with classic clinicopathological features and patients' survival KA Bouchagier, SF Assimakopoulos, DD Karavias, I Maroulis, V Tzelepi, ... In Vivo 28 (3), 315-326, 2014 | 44 | 2014 |
| Epigenetics and prostate cancer: defining the timing of DNA methyltransferase deregulation during prostate cancer progression V Tzelepi, S Logotheti, E Efstathiou, P Troncoso, A Aparicio, M Sakellakis, ... Pathology 52 (2), 218-227, 2020 | 41 | 2020 |
| Estrogen receptor α/β, AIB1, and TIF2 in colorectal carcinogenesis: do coregulators have prognostic significance? PD Grivas, V Tzelepi, G Sotiropoulou-Bonikou, Z Kefalopoulou, ... International journal of colorectal disease 24, 613-622, 2009 | 41 | 2009 |
| Expression of ERα, ERβ and Co-regulator PELP1/MNAR in colorectal cancer: prognostic significance and clinicopathologic correlations PD Grivas, V Tzelepi, G Sotiropoulou-Bonikou, Z Kefalopoulou, ... Analytical Cellular Pathology 31 (3), 235-247, 2009 | 40 | 2009 |
| Hedgehog signaling inhibition by the small molecule smoothened inhibitor GDC‐0449 in the bone forming prostate cancer xenograft MDA PCa 118b M Karlou, JF Lu, G Wu, S Maity, V Tzelepi, NM Navone, A Hoang, ... The Prostate 72 (15), 1638-1647, 2012 | 38 | 2012 |
